By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pluristem Therapeutics 

New York  New York    U.S.A.
Phone: n/a Fax: n/a



Company News
Pluristem Therapeutics (PSTI) Granted U.S. Patent For Production Methods And Use Of Placental Cell Therapy In A Range Of Indications 8/17/2015 6:08:28 AM
Japan Grants Safety Clearance To Pluristem Therapeutics (PSTI)'s PLX-PAD Cells For Use In Clinical Trials 8/12/2015 8:12:21 AM
Pluristem Therapeutics (PSTI) In Key Discussions With Europe's Adaptive Pathways Group On Phase II Protocol In Critical Limb Ischemia 8/10/2015 7:41:34 AM
New Data Show Pluristem Therapeutics (PSTI)s PLX Cells Regulate The Immune System 7/27/2015 7:42:42 AM
Pluristem Therapeutics (PSTI) Announces Pricing Of Registered Direct Offering Of Common Stock And Warrants 6/25/2015 7:54:24 AM
Pluristem Therapeutics (PSTI) Awarded $2.9 Million Grant By Israeli Government 6/17/2015 7:03:18 AM
Pluristem Therapeutics (PSTI) Awarded Grant From Israel's Ministry Of Economy For Marketing Its PLX Cell Therapy In Japan 6/3/2015 7:27:50 AM
Pluristem Therapeutics (PSTI) Granted Key Cell Patents In Asia, Russia, Mexico, And Israel 6/1/2015 10:42:42 AM
Pluristem Therapeutics (PSTI) To Present At The International Congress Of Radiation Research And Chair Two Panels At The Annual Meeting Of The International Society For Cellular Therapy 5/27/2015 7:58:49 AM
Pluristem Therapeutics (PSTI) Issues Letter To Shareholders 5/26/2015 6:42:58 AM